GEOVAX, INC.
GEOVAX, INC. is a federal contractor, registered under UEI CEF5ULT44LF5 and CAGE code 4DG62. It has been awarded $25,687,904 in federal contracts. Primary work spans Unknown NAICS and Research and Development in Biotechnology. Top awarding agencies include Department Of Health And Human Services and Department Of Defense.
Contact Information
Registration and classification details
Registration
UEI Code
CEF5ULT44LF5CAGE Code
4DG62Entity Structure
Corporate Entity (Not Tax Exempt)Established
N/ABusiness Classifications
NAICS Codes
Federal Contracting Overview
Award totals, agency breakdown, NAICS distribution, and geographic footprint.
AI Capability Profile
GEOVAX, INC. specializes in biomedical research and development services, with a technical focus on vaccine design, immunological assay development, and preclinical therapeutic evaluation. The company leverages proprietary platforms to advance novel vaccine candidates against infectious diseases, ap...
GEOVAX, INC. specializes in biomedical research and development services, with a technical focus on vaccine design, immunological assay development, and preclinical therapeutic evaluation. The company leverages proprietary platforms to advance novel vaccine candidates against infectious diseases, applying molecular biology, virology, and immunogenetics to engineer recombinant viral vector systems. Their expertise includes antigen design, vector optimization, and in vivo immunogenicity testing, supporting the transition of candidates from laboratory discovery to regulatory-ready preclinical packages. Differentiators include integrated platform technologies that enhance immune response durability and cross-reactivity, positioning them as a niche provider in next-generation vaccine innovation. Award history does not provide sufficient detail to identify specific federal agencies or program relationships. Consequently, no confirmed patterns of engagement with government entities can be inferred from available data. The primary NAICS code 541714 reflects research and development in the life sciences, specifically in biotechnology and biomedical engineering. In practice, this means GEOVAX operates at the intersection of academic research and government-funded biodefense or public health preparedness initiatives, delivering R&D services that support the development of medical countermeasures. Their market positioning is that of a specialized biotech contractor focused on early-stage vaccine innovation rather than commercial manufacturing or large-scale clinical trial execution. GEOVAX, INC. is structured as a small business (2L) headquartered in Smyrna, Georgia. The company holds no federal certifications such as 8(a), HUBZone, or WOSB. Its geographic presence is concentrated in Georgia, with operations centered on laboratory-based R&D rather than nationwide service delivery. The business operates as a technical services provider within the federal biodefense and health security ecosystem, relying on scientific expertise rather than broad compliance or infrastructure capabilities to compete for research contracts.
Key Performance Metrics
Awards Count
10
All time
Active
0
Currently performing
Completed
10
Past period of performance
Total Awards
All time
Contracts
Prime · all time
Subcontracts
Sub · all time
Grants
Prime · all time
Subgrants
Sub · all time
Award Analytics & Distribution
Compete with GEOVAX, INC.
Track the contractors you bid against, and the work they win
Award history, agency mix, and NAICS coverage for GEOVAX, INC.
AI-powered matching against your own capabilities and past performance
Teaming and subcontracting signals on every award
Automated alerts when a competitor wins in your market
Join 750+ contractors already using CLEATUS
